HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Garden Of Life Survey Points To Consumer Preference For Carbon-Neutral Product Providers

Executive Summary

More than 4 in 5 American adults expect companies to be carbon neutral consider a company’s climate impact and sustainability record when selecting a product, research conducted by certified carbon neutral dietary supplement brand Garden of Life reports.

You may also be interested in...



Amazon Becomes ‘Aware,’ Launches Own Eco-Certified Skin-Care And Other Offerings

Amazon is expanding its private-label beauty portfolio with the rollout of Amazon Aware, an ‘everyday essentials’ collection comprising skin care, home and apparel items certified in accordance with its Climate Pledge Friendly program.

HBW Insight’s Key Takeaways From 2021: #2 Get Serious About Sustainability

In 2021 the consumer health industry ramped up its sustainability efforts, with many firms publishing ambitious “net zero” transition strategies. As 2022 gets underway, recyclable or reusable packaging and consumer behavior change stand out as priority areas for further work, alongside carbon emissions reduction. To counter potential accusations of “greenwashing,” companies must be truthful and transparent about their ESG progress.

Demand For Immunity Boosters Lifts Nestlé Health Science

Nestlé Health Science saw sales rise double digits in 2020 thanks to higher demand for health and immunity products during the pandemic.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

RS152421

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel